Regeneron Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
09.06.25
/
50%
€444.50
Target price
09.06.26
€700.56
Performance (%)
46.18%
Price
14.01.26
€648.00
Summary
This prediction is currently active. With a performance of 46.18% the BUY prediction by JPMorgan_Chase___Co_ is a big success. Dividends of €1.76 are taken into consideration when calculating the performance. This prediction currently runs until 09.06.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | -6.870% | -6.870% |
| iShares Core DAX® | 0.721% | 4.566% |
| iShares Nasdaq 100 | -0.413% | 1.884% |
| iShares Nikkei 225® | 3.500% | 7.196% |
| iShares S&P 500 | 0.489% | 2.436% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $950.00 to $800.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€586.00
31.03.25
31.03.25
€922.40
31.03.26
31.03.26
11.03%
14.01.26
14.01.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€872.60
24.10.24
24.10.24
€1,064.9
24.10.25
24.10.25
-42.87%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€990.00
02.08.24
02.08.24
€1,099.6
02.08.25
02.08.25
-51.29%
03.08.25
03.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€974.20
17.06.24
17.06.24
€1,072.3
17.06.25
17.06.25
-54.45%
18.06.25
18.06.25